Background: The post‐thrombotic syndrome is a chronic, poorly understood complication of
deep venous thrombosis (DVT). Objectives: To evaluate predictors of the post‐thrombotic …

Abstract Objective Direct oral anticoagulants (DOACs) have been recommended for the
treatment of deep vein thrombosis (DVT). However, the benefits are uncertain for the …

Up to half of patients with proximal deep vein thrombosis (DVT) will develop post-thrombotic
syndrome (PTS) despite optimal anticoagulant therapy. PTS significantly impacts upon …

The post-thrombotic syndrome (PTS) is an important chronic complication of deep vein
thrombosis (DVT). The present review focuses on risk determinants of PTS after DVT and …

Purpose: The long-term risk for recurrent deep venous thrombosis (DVT) and the incidence
of post-thrombotic syndrome (PTS) after long-term anticoagulation (LTA) therapy have been …

Background Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to
warfarin reduces the risk of post‐thrombotic syndrome (PTS) after deep vein thrombosis …

Background Post-thrombotic syndrome (PTS) is a frequent chronic complication of proximal
deep vein thrombosis (DVT) of the lower limb, but predictors of PTS are not well established …

The requirement for a safe diagnostic strategy of deep vein thrombosis (DVT) should be
based on an overall objective post incidence of venous thromboembolism (VTE) of less than …

Despite considerable progress in the diagnosis and treatment of deep vein thrombosis
(DVT) of the lower extremities, one in every two to three patients will develop, within 3 years …

Aims: We investigated the impact of the extent of primary deep venous thrombosis (DVT)
and recurrent thrombotic events in accordance to other presumed prognostic factors for long …